Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3 World

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

: Results Section for NCT03421379

Raw xml | Download


<Composition xmlns="http://hl7.org/fhir">
  <id value="267224"/>
  <meta>
    <versionId value="14"/>
    <lastUpdated value="2026-09-02T17:15:21.850Z"/>
    <profile
             value="http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-report"/>
  </meta>
  <language value="en"/>
  <text>
    <status value="extensions"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Composition 267224</b></p><a name="267224"> </a><a name="hc267224"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">version: 14; Last updated: 2026-09-02 17:15:21+0000</p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-evidence-report.html">EvidenceReport</a></p></div><p><b>Artifact Description</b>: </p><div><p>An evidence report summarizing the Results Section of a ClinicalTrials.gov record entry</p>
</div><p><b>ArtifactPublicationStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/cited-artifact-status-type active}">Active</span></p><p><b>url</b>: <a href="https://fevir.net/resources/Composition/267224">https://fevir.net/resources/Composition/267224</a></p><p><b>identifier</b>: FEvIR Object Identifier/267224, <a href="http://terminology.hl7.org/7.3.0/NamingSystem-ClinicalTrials-Gov.html" title="The U.S. National Institutes of Health, Department of Health and Human Services, through its National Library of Medicine, has developed [ClinicalTrials.gov](http://clinicaltrials.gov) to provide patients, family members, and members of the public current information about clinical research studies. [ClinicalTrials.gov](http://clinicaltrials.gov) contains summary information about clinical studies being conducted throughout the United States and in many countries throughout the world. These data are provided to the National Library of Medicine by organizations and institutions that sponsor and implement the studies.

[ClinicalTrials.gov](http://clinicaltrials.gov) is updated daily. You should check [ClinicalTrials.gov](http://clinicaltrials.gov) frequently for updated information.

More information about ClinicalTrials.gov can be found [here](https://clinicaltrials.gov/about-site/about-ctg).">ClinicalTrials.gov</a>/NCT03421379 (use: official, ), FEvIR Linking Identifier/NCT03421379 Results Report</p><p><b>status</b>: Final</p><p><b>type</b>: <span title="Codes:">EvidenceReport</span></p><p><b>category</b>: <span title="Codes:">ClinicalTrials.gov Study Results</span></p><p><b>date</b>: 2026-09-02 17:15:21+0000</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter</p><p><b>name</b>: NCT03421379_Results</p><p><b>title</b>: Results Section for NCT03421379</p><blockquote><p><b>classification</b></p><p><b>type</b>: <span title="Codes:{https://fevir.net/resources/CodeSystem/179423 population}">Population</span></p><h3>Classifiers</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://www.nlm.nih.gov/mesh D003920}">Diabetes Mellitus</span></td></tr></table></blockquote><blockquote><p><b>classification</b></p><p><b>type</b>: <span title="Codes:{https://fevir.net/resources/CodeSystem/179423 intervention}">Intervention</span></p><h3>Classifiers</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://www.nlm.nih.gov/mesh D052216}">Glucagon-Like Peptide 1</span></td></tr></table></blockquote><p><b>custodian</b>: <a href="Organization-118079.html">Computable Publishing LLC</a></p><blockquote><p><b>relatesTo</b></p><p><b>type</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/artifact-relationship-type derived-from}">Derived From</span></p><p><b>target</b>: <a href="https://clinicaltrials.gov/api/query/full_studies?expr=NCT03421379&amp;max_rnk=1&amp;fmt=JSON">https://clinicaltrials.gov/api/query/full_studies?expr=NCT03421379&amp;max_rnk=1&amp;fmt=JSON</a></p></blockquote><blockquote><p><b>relatesTo</b></p><p><b>type</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/artifact-relationship-type cite-as}">Cite As</span></p><p><b>target</b>: </p><div><p>Results Section for NCT03421379 [Database Entry: FHIR Composition Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 267224. Revised 2026-09-02. Available at: https://fevir.net/resources/Composition/267224. Computable resource at: https://fevir.net/resources/Composition/267224#json.</p>
</div></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: PractitionerRole #PointOfContact</b></p><a name="267224/PointOfContact"> </a><a name="hc267224/PointOfContact"> </a><p><b>practitioner</b>: Chief Medical Officer</p><p><b>organization</b>: Eli Lilly and Company</p><h3>Contacts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Telecom</b></td></tr><tr><td style="display: none">*</td><td><a href="mailto:ClinicalTrials.gov@lilly.com">ClinicalTrials.gov@lilly.com</a></td></tr><tr><td style="display: none">*</td><td>ph: 800-545-5979</td></tr></table></blockquote></div>
  </text>
  <contained>
    <PractitionerRole>
      <id value="PointOfContact"/>
      <practitioner>
        <display value="Chief Medical Officer"/>
      </practitioner>
      <organization>
        <display value="Eli Lilly and Company"/>
      </organization>
      <contact>
        <telecom>
          <system value="email"/>
          <value value="ClinicalTrials.gov@lilly.com"/>
        </telecom>
      </contact>
      <contact>
        <telecom>
          <system value="phone"/>
          <value value="800-545-5979"/>
        </telecom>
      </contact>
    </PractitionerRole>
  </contained>
  <extension
             url="http://hl7.org/fhir/StructureDefinition/artifact-description">
    <valueMarkdown
                   value="An evidence report summarizing the Results Section of a ClinicalTrials.gov record entry"/>
  </extension>
  <extension
             url="http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status">
    <valueCodeableConcept>
      <coding>
        <system
                value="http://terminology.hl7.org/CodeSystem/cited-artifact-status-type"/>
        <code value="active"/>
        <display value="Active"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <url value="https://fevir.net/resources/Composition/267224"/>
  <identifier>
    <type>
      <coding>
        <system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
        <code value="ACSN"/>
        <display value="Accession ID"/>
      </coding>
      <text value="FEvIR Object Identifier"/>
    </type>
    <system value="https://fevir.net/FOI"/>
    <value value="267224"/>
    <assigner>
      <display value="Computable Publishing LLC"/>
    </assigner>
  </identifier>
  <identifier>
    <use value="official"/>
    <system value="https://clinicaltrials.gov/nctid"/>
    <value value="NCT03421379"/>
  </identifier>
  <identifier>
    <type>
      <text value="FEvIR Linking Identifier"/>
    </type>
    <system value="https://fevir.net/FLI"/>
    <value value="NCT03421379 Results Report"/>
    <assigner>
      <display value="Computable Publishing LLC"/>
    </assigner>
  </identifier>
  <status value="final"/>
  <type>
    <text value="EvidenceReport"/>
  </type>
  <category>
    <text value="ClinicalTrials.gov Study Results"/>
  </category>
  <subject>🔗 
    <reference value="ResearchStudy/267223"/>
    <type value="ResearchStudy"/>
    <identifier>
      <type>
        <text value="FEvIR Linking Identifier"/>
      </type>
      <system value="https://fevir.net/FLI"/>
      <value value="NCT03421379 FHIR Transform"/>
      <assigner>
        <display value="Computable Publishing LLC"/>
      </assigner>
    </identifier>
    <display
             value="A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus"/>
  </subject>
  <date value="2026-09-02T17:15:21.850Z"/>
  <author>
    <display
             value="Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter"/>
  </author>
  <name value="NCT03421379_Results"/>
  <title value="Results Section for NCT03421379"/>
  <classification>
    <type>
      <coding>
        <system value="https://fevir.net/resources/CodeSystem/179423"/>
        <code value="population"/>
        <display value="Population"/>
      </coding>
    </type>
    <classifier>
      <concept>
        <coding>
          <system value="https://www.nlm.nih.gov/mesh"/>
          <code value="D003920"/>
          <display value="Diabetes Mellitus"/>
        </coding>
      </concept>
    </classifier>
  </classification>
  <classification>
    <type>
      <coding>
        <system value="https://fevir.net/resources/CodeSystem/179423"/>
        <code value="intervention"/>
        <display value="Intervention"/>
      </coding>
    </type>
    <classifier>
      <concept>
        <coding>
          <system value="https://www.nlm.nih.gov/mesh"/>
          <code value="D052216"/>
          <display value="Glucagon-Like Peptide 1"/>
        </coding>
      </concept>
    </classifier>
  </classification>
  <custodian>🔗 
    <reference value="Organization/118079"/>
    <type value="Organization"/>
    <display value="Computable Publishing LLC"/>
  </custodian>
  <relatesTo>
    <type>
      <coding>
        <system
                value="http://terminology.hl7.org/CodeSystem/artifact-relationship-type"/>
        <code value="derived-from"/>
        <display value="Derived From"/>
      </coding>
    </type>
    <targetUri
               value="https://clinicaltrials.gov/api/query/full_studies?expr=NCT03421379&amp;max_rnk=1&amp;fmt=JSON"/>
  </relatesTo>
  <relatesTo>
    <type>
      <coding>
        <system
                value="http://terminology.hl7.org/CodeSystem/artifact-relationship-type"/>
        <code value="cite-as"/>
        <display value="Cite As"/>
      </coding>
    </type>
    <targetMarkdown
                    value="Results Section for NCT03421379 [Database Entry: FHIR Composition Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 267224. Revised 2026-09-02. Available at: https://fevir.net/resources/Composition/267224. Computable resource at: https://fevir.net/resources/Composition/267224#json."/>
  </relatesTo>
  <section>
    <title value="Participant Flow Module"/>
    <code>
      <text value="ParticipantFlowModule"/>
    </code>
    <entry>🔗 
      <reference value="Composition/399871"/>
      <type value="Composition"/>
      <identifier>
        <type>
          <text value="FEvIR Linking Identifier"/>
        </type>
        <system value="https://fevir.net/FLI"/>
        <value value="NCT03421379-participant-flow-report"/>
        <assigner>
          <display value="Computable Publishing LLC"/>
        </assigner>
      </identifier>
      <display value="Participant Flow Report for NCT03421379"/>
    </entry>
  </section>
  <section>
    <title value="Baseline Characteristics Module"/>
    <code>
      <text value="BaselineCharacteristicsModule"/>
    </code>
    <entry>🔗 
      <reference value="Composition/399872"/>
      <type value="Composition"/>
      <identifier>
        <type>
          <text value="FEvIR Linking Identifier"/>
        </type>
        <system value="https://fevir.net/FLI"/>
        <value value="NCT03421379-baseline-measure-report"/>
        <assigner>
          <display value="Computable Publishing LLC"/>
        </assigner>
      </identifier>
      <display value="Baseline Characteristics Report for NCT03421379"/>
    </entry>
  </section>
  <section>
    <title value="Outcome Measures Module"/>
    <code>
      <text value="OutcomeMeasuresModule"/>
    </code>
    <entry>🔗 
      <reference value="Composition/399873"/>
      <type value="Composition"/>
      <identifier>
        <type>
          <text value="FEvIR Linking Identifier"/>
        </type>
        <system value="https://fevir.net/FLI"/>
        <value value="NCT03421379-outcome-measure-report"/>
        <assigner>
          <display value="Computable Publishing LLC"/>
        </assigner>
      </identifier>
      <display value="Outcome Measures Report for NCT03421379"/>
    </entry>
  </section>
  <section>
    <title value="Adverse Events Module"/>
    <code>
      <text value="AdverseEventsModule"/>
    </code>
    <entry>🔗 
      <reference value="Composition/399874"/>
      <type value="Composition"/>
      <identifier>
        <type>
          <text value="FEvIR Linking Identifier"/>
        </type>
        <system value="https://fevir.net/FLI"/>
        <value value="NCT03421379-adverse-events-report"/>
        <assigner>
          <display value="Computable Publishing LLC"/>
        </assigner>
      </identifier>
      <display value="Adverse Events Report for NCT03421379"/>
    </entry>
  </section>
  <section>
    <title value="More Info Module"/>
    <code>
      <text value="MoreInfoModule"/>
    </code>
    <section>
      <title value="Certain Agreement"/>
      <code>
        <text value="CertainAgreement"/>
      </code>
      <entry>
        <display value="AgreementPISponsorEmployee False"/>
      </entry>
      <entry>
        <display value="AgreementRestrictionType GT60"/>
      </entry>
      <entry>
        <display value="AgreementRestrictiveAgreement True"/>
      </entry>
    </section>
    <section>
      <title value="Point Of Contact"/>
      <code>
        <text value="PointOfContact"/>
      </code>
      <text>
        <status value="generated"/>
        <div xmlns="http://www.w3.org/1999/xhtml">Chief Medical Officer, Eli Lilly and Company</div>
      </text>
      <entry>
        <reference value="#PointOfContact"/>
        <type value="PractitionerRole"/>
        <display value="Chief Medical Officer, Eli Lilly and Company"/>
      </entry>
    </section>
  </section>
</Composition>